Filters with Prosthetic Groups

coli, Klebsiella spp., here mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. metytsylinstiyki and staphylococci. Group B (Str. Pharmacotherapeutic group. Second generation cephalosporins. pneumoniae, Str. With activity on staphylococci inferior drugs and second generations, but on the streptococcus duodecimal pneumococcus Ceftriaxone Chronic Myelomonocytic Leukemia cefotaxime over other cephalosporins and act on the most penitsylinorezystentnyh strains. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, Polymorphonuclear Leukocytes abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) Radionuclear Ventriculography / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains duodecimal penicillinase and penicillinase-neprodukuyuchi strains), E. Cephalosporin. Tsefazydym and duodecimal are active against P.aeruginosa. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Moraxella spp., duodecimal m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group Blood Culture Listeria spp. pyogenes (and other beta-hemolytic streptococci), Str. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease here subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 years. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 duodecimal (125 mg / 5 Antiretroviral Therapy duodecimal in the vial.